These results indicated that the NORAD/miR-224-3p/MTDH axis might promote CDDP resistance in ESCC by activating β-catenin signalling rather than Akt, MAPK or NF-κB. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.